Journal: medRxiv
Article Title: Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases
doi: 10.1101/2023.06.17.23289722
Figure Lengend Snippet: Panel A: Meta-analysis of the distribution of LOY in Tregs (n = 2, cells = 203), Th (n = 4, cells = 1818) and CTL (n = 3, cells = 1441) lymphocytes located in the uninvolved margin (UM) and Tregs (n = 4, cells = 498), Th (n = 4, cells = 1460) and CTL (n = 3, cells = 681) located in tumor of male patients with CRC. Panel B: Experimental analysis of the distribution of LOY in Regulatory T lymphocytes (Tregs), Helper T lymphocytes (Th) and CD8+ cytotoxic T cells (CTL) in blood samples collected from 49 CRC patients and 19 healthy controls. CRC – colorectal cancer, Ctrl – age-matched control patients without prior diagnoses of cancer and Alzheimer’s disease. Panel C: Meta-analysis of distribution of LOY in Tregs and Th in eight different cancer types: CRC -colorectal cancer (n = 10, cells = 3349); HCC – hepatocellular carcinoma (n = 9, cells = 8329); ICC – intrahepatic cholangiocarcinoma (n = 1, cells = 222); CM – cutaneous melanoma (n = 24, cells = 13306); PDAC – pancreatic ductal adenocarcinoma (n = 4, cells = 845); BCC – basal cell carcinoma (n = 8, cells = 14053); SCC – squamous-cell carcinomas (n = 8, cells = 13889); UvM – uveal melanoma (n = 1, cells = 248). Panel D: Meta-analysis of distribution of %LOY in CD45+ immune cells located in TME of different cancers. CRC – colorectal cancer (n = 10, cells = 11165), HCC – hepatocellular carcinoma (n = 16, cells = 21604), ICC – intrahepatic cholangiocarcinoma (n = 5, cells = 1497), CM – cutaneous melanoma (n = 33, cells = 41087), PDAC – pancreatic ductal adenocarcinoma (n = 11, cells = 4749), BCC – basal cell carcinoma (n = 8, cells = 35359), SCC – squamous-cell carcinomas (n = 4, cells = 25924), UvM – uveal melanoma (n = 4, cells = 5018).
Article Snippet: Granulocytes were sorted according to SSC/FSC parameters and CD45+ expression antigen (BD Bioscience).
Techniques: